FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|8|1|69-75

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.8, Iss.1, 2015-05, pp. : 69-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential effects of S-ketamine and R-ketamine on psychopathology and brain energy metabolism measured by FDG-PET in humans

By Vollenweider F.X.   Leenders K.L.   Oslashye I.   Scharfetter C.   Angst J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 319-319

Elsevier

Access to resources Recommend Favorite

FDG-PET worthwhile in head and neck cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Immobilization stress-induced changes in brain acetylcholinesterase activity and cognitive function in mice

By Das A.   Kapoor K.   Sayeepriyadarshini A.T.   Dikshit M.   Palit G.   Nath C.  

Pharmacological Research, Vol. 42, Iss. 3, 2000-09 ,pp. : 213-217

Academic Press

Access to resources Recommend Favorite

VI. FDG‐PET as a biomarker in lymphoma: from qualitative to quantitative analysis

By  

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 38-41

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [ 18 F]fluorodeoxyglucose (FDG)

By Vollenweider F.X.   Leenders K.L.   Scharfetter C.   Antonini A.   Maguire P.   Missimer J.   Angst J.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 9-24

Elsevier

Access to resources Recommend Favorite